_10-year-old-obese-girl-suffers-shocking-heart-attack-124-house-m-d-124-md-tv-preview-1.jpg "10-Year-Old Obese Girl Suffers Shocking Heart Attack | House M.D. | MD TV from obese girl Video Screenshot Preview 1")
Gallery_10-year-old-obese-girl-suffers-shocking-heart-attack-124-house-m-d-124-md-tv-preview-3.jpg "10-Year-Old Obese Girl Suffers Shocking Heart Attack | House M.D. | MD TV from obese girl Video Screenshot Preview 3")
Gallery_10-year-old-obese-girl-suffers-shocking-heart-attack-124-house-m-d-124-md-tv-preview-hqdefault.jpg "10-Year-Old Obese Girl Suffers Shocking Heart Attack | House M.D. | MD TV from obese girl Video Screenshot Preview hqdefault")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
Jump To Video Parts
⏲ Duration: 10 minutes 7 seconds
👁 View: 206.3K times
Play Audio:👁 View: 206.3K times
Description:
MD TV
MD TV
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_obese-girl-loses-66-pounds-maintains-healthy-weight-and-diet-124-good-morning-america-124-abc-news.webp "ABC News")
⏲ 4 minutes 46 seconds 👁 4.9M
_save-my-obese-daughter.webp "The Doctors")
_latest-weight-loss-drug-faces-shortages.webp "Latest Weight-Loss Drug , Faces Shortages .<br/>The United States Food and Drug Administration <br/>(FDA) says that high demand has left the latest <br/>weight-loss drug, Zepbound, in short supply.<br/>'Newsweek' reports that the Eli Lilly product<br/>is expected to experience limited availability <br/>through Q2 of 2024 as surging demand has <br/>outpaced the manufacturer's expectations.<br/>We have experienced <br/>an unparalleled surge in <br/>demand for our type 2 <br/>diabetes and obesity medicines, Eli Lilly spokesperson, via 'Newsweek'.<br/>We recognize this situation may <br/>cause a disruption in peoples' <br/>treatment regimens and are <br/>working with purpose and <br/>urgency to help meet <br/>the surge in demand, Eli Lilly spokesperson, via 'Newsweek'.<br/>The FDA said that Novo Nordisk's weight-loss <br/>drug, Wegovy, is also experiencing a <br/>widespread supply shortage with no end <br/>in sight for the drug's limited availability.<br/>By the year 2030, 'Newsweek' reports <br/>that the weight-loss drug market is <br/>expected to grow to about $100 billion.<br/>We expect our investments <br/>in manufacturing and supply <br/>capacity to progressively increase <br/>production of our medicines <br/>throughout 2024 and beyond, Eli Lilly spokesperson, via 'Newsweek'.<br/>Over the past year, manufacturer Eli Lilly <br/>has already seen share prices rise over 102%.<br/>The company has announced plans <br/>to expand operations to meet increased <br/>demand for its incretin products which are <br/>used in the firm's diabetes treatments. .<br/>Incretin mimics gut hormones <br/>that regulate blood sugar <br/>while also suppressing appetite")
_after-pcos-led-to-obesity-this-woman-lost-almost-200-pounds-124-today.webp "TODAY")
_gregg-wallace-believes-he-should-receive-a-statue-for-saving-the-nation-from-obesity.webp "Gregg Wallace is determined to see a statue build in his honour after \")
_ashley39s-extreme-weight-loss-makeover.webp "ABC News")
_mom-needs-help-for-her-overweight-7-year-old.webp "The Doctors")
_the-life-sciences-present-a-golden-opportunity-for-investors-learn-how.webp "The Life Science industry may present a promising investment opportunity. At the forefront of innovation, the industry is poised to benefit from new technologies like artificial intelligence. The pace of new drug development, for instance, is rapidly accelerating; in 2002 there were 17 new drugs approved, and in 2023, there were nearly 60.<br/><br/>Tema ETFs, an active investment adviser, offers three ETFs focused on life sciences – CANC, HRTS and MNTL.<br/><br/>CANC is Tema's Oncology ETF, investing in the prevention of and cure for cancer.<br/><br/>HRTS is Tema's Obesity and Cardiometabolic ETF, addressing the obesity epidemic.<br/><br/>MNTL is Tema's Neuroscience and Mental Health ETF, investing in the future of cognitive health and science.")
_obese-girl-loses-66-pounds-maintains-healthy-weight-and-diet-124-good-morning-america-124-abc-news.jpg)
_save-my-obese-daughter.jpg)
_latest-weight-loss-drug-faces-shortages.jpg)
_after-pcos-led-to-obesity-this-woman-lost-almost-200-pounds-124-today.jpg)
_gregg-wallace-believes-he-should-receive-a-statue-for-saving-the-nation-from-obesity.jpg)
_ashley39s-extreme-weight-loss-makeover.jpg)
_mom-needs-help-for-her-overweight-7-year-old.jpg)
_the-life-sciences-present-a-golden-opportunity-for-investors-learn-how.jpg)
![[+]](/images/menu.gif){kind=small}